TABLE 4.
Groups |
Subgroup A (1 mo) |
Subgroup B (2 mo) |
Subgroup C (3 mo) |
P‐value | |||
---|---|---|---|---|---|---|---|
Mean | SD | Mean | SD | Mean | SD | ||
Group I (blood clot) | 0.33aA | 0.47 | 1.25aB | 0.43 | 2.08aC | 0.28 | ≤.001* |
Group II (EDT + blood clot) | 0.50bA | 0.50 | 1.50aB | 0.50 | 2.33bC | 0.47 | ≤.001* |
Group III (PRF) | 0.67cA | 0.47 | 2.00 bB | 0.00 | 2.50 bC | 0.50 | ≤.001* |
Group IV (EDTA + PRF) | 1.42dA | 0.49 | 2.17bB | 0.37 | 2.67cC | 0.50 | ≤.001* |
Group V (positive control) | 0.50bA | 0.50 | 0.58cA | 0.49 | 0.58dA | 0.49 | 1.00 NS |
P‐value | ≤0.001* | ≤0.001* | ≤0.001* |
The same upper‐case letters within each row indicate differences that were not significant.
The same lower‐case letters within each column indicate differences that were not significant.
Abbreviation: NS, not significant.
Significant at P ≤ .05.